ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,164Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 15

$775K Total Retail Price of All Prescriptions

Rank: 2 out of 15

319 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 319 patients filled at least one prescription for a schedule two drug, compared to an average of 15%.

Schedule Three
Controlled Substances

5% of this provider’s 319 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

0% of this provider’s 11,214 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 26.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
LEVOTHYROXINE SODIUM 584 555 1 3
METOPROLOL TARTRATE 557 497 2 4
FUROSEMIDE 533 516 3 2
WARFARIN SODIUM 493 490 4 1
SERTRALINE HCL 380 350 5 5
SIMVASTATIN 336 303 6 7
LISINOPRIL 305 241 7 6
TRAMADOL HCL 286 261 8 10
AMLODIPINE BESYLATE 270 228 9 11
TRAZODONE HCL 265 214 10 16
RISPERIDONE 261 220 11 15
DONEPEZIL HCL 256 228 12 9
POTASSIUM CHLORIDE 198 180 13 19
CITALOPRAM HBR 196 157 14 13
QUETIAPINE FUMARATE 187 172 15 31
NAMENDA 167 151 16 17
RAMIPRIL 166 152 17 50
LANTUS 165 135 18 21
METOPROLOL SUCCINATE 164 121 19 14
MIRTAZAPINE 147 144 20 12
ISOSORBIDE MONONITRATE ER 138 138 21 26
OMEPRAZOLE 138 107 21 8
DIVALPROEX SODIUM 128 84 23 34
METFORMIN HCL 128 82 23 32
GABAPENTIN 126 78 25 18
PAROXETINE HCL 118 104 26 46
ATORVASTATIN CALCIUM 114 97 27 23
CARBIDOPA-LEVODOPA 111 100 28 43
ATENOLOL 108 85 29 33
GLIPIZIDE 104 91 30 44
PREDNISONE 102 87 31 35
OXYBUTYNIN CHLORIDE ER 101 83 32 77
SPIRIVA 100 98 33 22
HYDROCHLOROTHIAZIDE 96 96 34 37
LEVETIRACETAM 94 82 35 61
IPRATROPIUM-ALBUTEROL 92 89 36 39
DIGOXIN 92 92 36 45
CIPROFLOXACIN HCL 88 72 38 53
TAMSULOSIN HCL 87 77 39 29
OLANZAPINE 86 67 40 40
KLOR-CON M20 82 72 41 36
FLUOXETINE HCL 81 72 42 50
SULFAMETHOXAZOLE-TRIMETHOPRIM 80 72 43 83
METHENAMINE HIPPURATE 78 63 44 84
OXYCODONE HCL 76 68 S2 45 25
BACLOFEN 74 17 46 57
LEVEMIR FLEXPEN 74 61 46 86
CARVEDILOL 74 74 46 60
ALLOPURINOL 71 71 49 49
ADVAIR DISKUS 71 68 49 24
SEROQUEL 67 60 51 88
NYSTATIN 67 54 51 41
SPIRONOLACTONE 66 43 53 46
CYCLOBENZAPRINE HCL 65 15 R 54 72
CLOPIDOGREL 65 63 54 64
HYDROCODONE-ACETAMINOPHEN 64 42 S3 56 27
GLIPIZIDE ER 63 50 57 91
HYDRALAZINE HCL 63 47 57 70
CYMBALTA 62 40 59 28
NYSTATIN-TRIAMCINOLONE 59 47 60 96
DOXYCYCLINE HYCLATE 58 30 61 97
VENLAFAXINE HCL ER 56 27 62 54
TOPIRAMATE 55 27 63 102
MORPHINE SULFATE 52 35 S2 64 73
ESCITALOPRAM OXALATE 52 52 64 38
TIMOLOL MALEATE 52 52 64 106
NOVOFINE AUTOCOVER 50 42 67 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.